• Top hematology/oncology stories: Palliative care could reduce suicide risk, FDA approves Khapzory for injection

    13 days ago - By Healio

    The top two stories in hematology/oncology this week included study results that suggested that palliative care could reduce suicide risk among veterans with advanced lung cancer and the FDA approval of Khapzory as an injection treatment to prevent several adverse events related to chemotherapy.
    Other popular stories came from the European Society for Medical Oncology Congress meeting in Munich, including studies that found that first-line pembrolizumab is a new standard for recurrent, metastatic head and neck squamous cell carcinoma; data showing the avelumab-axitinib combination may be a new
    Read more ...